GlassScriptPhysician profile
Eric J Adrignola
NPI 1750975181
$1,853.71
in general payments reported to CMS, 2019-2025
9 companies · $21.95 in 2025
The $21.95 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $545 · 2022: $1,041 · 2023: $246 · 2025: $21.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $611.87 | 2021-2023 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $383.20 | 2021-2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $338.69 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $199.02 | 2021-2023 | Rexulti |
| Lundbeck LLC | $164.92 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $102.37 | 2021-2022 | |
| Boston Scientific Corporation | $21.95 | 2025 | Solyx Sis System |
| Almatica Pharma LLC | $20.43 | 2023 | Loreev Xr |
| Eisai INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Adrignola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.